100.00% -1.60

Talis Biomedical Corp (TLIS)

개요 뉴스 가격 이력 Financials 토론 예측 주식 분할

Relative Volume:

Talis Biomedical Corp Stock (TLIS) Company Profile

Talis Biomedical Corp

Healthcare (1116)

Medical Devices (144)

최신 SEC 제출 서류

TLIS's Discussions on Twitter

Compare TLIS vs ABT, SYK, MDT, BSX, EW

주식	가격	시가총액	매출	순이익	현금흐름	주당 순 이익
TLIS Talis Biomedical Corp	0.00	0	368.00K	-75.48M	-56.05M	-41.86
ABT Abbott Laboratories	109.95	191.06B	44.33B	6.50B	7.40B	3.717
SYK Stryker Corp	349.56	133.77B	25.12B	3.25B	4.28B	8.3984
MDT Medtronic Plc	88.24	113.29B	35.48B	4.64B	5.41B	3.582
BSX Boston Scientific Corp	69.79	103.56B	20.08B	2.89B	3.66B	1.9391
EW Edwards Lifesciences Corp	83.56	48.53B	6.07B	1.06B	1.34B	1.8063

Talis Biomedical Corp Stock (TLIS) Upgrades & Downgrades

날짜	액션	분석자	등급 변경
2022-01-07	다운그레이드	BofA Securities	Neutral → Underperform
2021-09-27	다운그레이드	JP Morgan	Neutral → Underweight
2021-08-31	다운그레이드	BTIG Research	Buy → Neutral
2021-08-12	다운그레이드	Piper Sandler	Overweight → Neutral
2021-08-11	다운그레이드	JP Morgan	Overweight → Neutral
2021-03-09	개시	BTIG Research	Buy
2021-03-09	개시	BofA Securities	Neutral
2021-03-09	개시	JP Morgan	Overweight
2021-03-09	개시	Piper Sandler	Overweight

Talis Biomedical Corp 주식(TLIS)의 최신 뉴스

Talis Biomedical Corp (TLIS) 재무 분석

Talis Biomedical Corp (TLIS)

Talis Biomedical Corp Stock (TLIS) Company Profile

Compare TLIS vs ABT, SYK, MDT, BSX, EW

Talis Biomedical Corp Stock (TLIS) Upgrades & Downgrades

Talis Biomedical Corp 주식(TLIS)의 최신 뉴스

TLIS Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan

Los Angeles Daily NewsTalis Biomedical Corporationcommon stock (Nasdaq:TLIS) Stock Quote - FinancialContent

Talis Biomedical Corp (NASDAQ: TLIS)Related Research - intelligentinvestor.com.au

TLIS EQUITY ALERT: Kessler Topaz Meltzer & Check, LLP Announces That a Securities Fraud Class Action Lawsuit Was Filed Against Talis Biomedical Corporation - Newsfile

Bronstein, Gewirtz & Grossman, LLC Notifies Shareholders Talis Biomedical Corporation (TLIS) Investigation - ACCESS Newswire

TLISTalis Biomedical Corp Latest Stock News & Market Updates - Stock Titan

TALIS BIOMEDICAL CORPORATION (NASDAQ: TLIS) SHAREHOLDER CLASS ACTION ALERT: Bernstein Liebhard LLP Announces that a Securities Class Action Lawsuit Has Been Filed Against Talis Biomedical Corporation (NASDAQ: TLIS) - ACCESS Newswire

Eligible Talis Biomedical Investors Could Claim a Share of $32.5 Million Settlement - Claim Depot

Baker Bros. Advisors LP's Strategic Acquisition in Talis Biomedical Corp - Yahoo Finance

Talis Biomedical Agrees to Settle Investor Suit for $33 Million - Bloomberg Law News

Biotech Investors Reach $32.5M Deal Over Failed COVID Test - Law360

Talis Biomedical ends Chicago office lease with $3.62 millio fee - Investing.com

Talis Biomedical executive buys $44,240 in company stock - Investing.com

Talis Biomedical settles lawsuit with Kriya Therapeutics - Investing.com

TLIS Stock Price and Chart — OTC:TLIS - TradingView — Track All Markets

Talis Biomedical executive buys $641 in stock - Investing.com

Talis Biomedical agrees to $32.5 million settlement - Investing.com

Talis Biomedical to be delisted from Nasdaq on September 3 - Investing.com

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday - InvestorPlace

Talis Biomedical Announces Board Shake-Up Amid Financial Struggles - TipRanks

Press Telegram - FinancialContent

Investors Win Class Cert. Against Failed COVID Test Maker - Law360

TALIS ALERT: Bragar Eagel & Squire, P.C. is Investigating - GlobeNewswire

Peninsula diagnostics company to close Redwood City labs and offices, pursue 'strategic alternatives' - The Business Journals

Talis Biomedical Corporation Announces Resignation of Felix Baker from the Board of Directors - marketscreener.com

Rustem F. Ismagilov Net Worth (2025) - GuruFocus

Talis Biomedical Announces Second Quarter 2023 Financial Results and Business Update - FinancialContent

Chemical spill prompts hazmat response, evacuation at Redwood Shores biomedical firm - CBS News

Whittier Daily News - FinancialContent

Talis Biomedical Announces Andrew Lukowiak, Ph.D., as President and Chief Scientific Officer (CSO) - Stock Titan

Talis Biomedical Regains Compliance with Nasdaq Minimum Bid Price Requirement - FinancialContent

Talis Biomedical Announces 1-for-15 Reverse Stock Split - FinancialContent

Daily Breeze - FinancialContent

Talis Biomedical Announces Business Update and First Quarter 2023 Financial Results | About Us | Oil & Gas Journal - FinancialContent

Talis Announces Fourth Quarter and Full Year 2022 Financial Results - GlobeNewswire

2022 Year-End Securities Litigation Update - Gibson Dunn

Billionaire hedge fund manager David Einhorn’s portfolio revealed - Daily Investor

Talis Biomedical Reports Third Quarter 2022 Financial Results - marketscreener.com

TALIS BIOMEDICAL CORP Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q) - MarketScreener

Talis Biomedical Corporation (TLIS) Q1 2022 Earnings Call Transcript - The Motley Fool

MannKind (MNKD) Reports Q1 Loss, Tops Revenue Estimates - Yahoo Finance

Talis Biomedical to Announce First Quarter 2022 Financial Results on May 10, 2022 - Yahoo Finance

Talis Biomedical Provides Business Update and Reports Fourth Quarter and Full Year 2021 Financial Results - GlobeNewswire

Oklahoma City NewsThe Oklahoman - FinancialContent

About Us - FinancialContent

Talis Biomedical to Announce Fourth Quarter and Full Year Financial Results on March 15, 2022 - Yahoo Finance

Bragar Eagel & Squire, P.C. Reminds Investors That Class - GlobeNewswire

PRN_FinancialWrapper - FinancialContent

Salt Lake City News, Weather, Sports, Breaking News | KUTVShareholder Action Reminder: The Schall Law Firm Encourages Investors in Talis Biomedical Corporation with Losses of $100,000 to Contact the Firm - FinancialContent

TLIS LAWSUIT ALERT: Levi & Korsinsky Notifies Talis Biomedical Corporation Investors of a Class Action Lawsuit and Upcoming Deadline - PR Newswire

User - FinancialContent

Talis Biomedical Corp (TLIS) 재무 분석

매출

순이익

현금흐름

주당 순 이익

TLIS과 유사한 종목